NO20075801L - Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose - Google Patents

Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose

Info

Publication number
NO20075801L
NO20075801L NO20075801A NO20075801A NO20075801L NO 20075801 L NO20075801 L NO 20075801L NO 20075801 A NO20075801 A NO 20075801A NO 20075801 A NO20075801 A NO 20075801A NO 20075801 L NO20075801 L NO 20075801L
Authority
NO
Norway
Prior art keywords
treating
osteoporosis
bone destruction
preventing bone
preventing
Prior art date
Application number
NO20075801A
Other languages
English (en)
Inventor
Robert E Dudley
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of NO20075801L publication Critical patent/NO20075801L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen angår en transdermal hydroalkoholisk testosterongelformulering og en fremgangsmåte for å behandle, forebygge eller redusere risikoen for å utvikle svekkelse av ben.Den foreliggende oppfinnelsen angår også en fremgangsmåte for å behandle, forebygge eller redusere risikoen for å utvikle osteoporose.
NO20075801A 2005-04-12 2007-11-12 Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose NO20075801L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67058005P 2005-04-12 2005-04-12
PCT/US2006/013551 WO2006110777A1 (en) 2005-04-12 2006-04-11 Method of treating or preventing bone deterioration or osteoporosis

Publications (1)

Publication Number Publication Date
NO20075801L true NO20075801L (no) 2008-01-07

Family

ID=37087357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075801A NO20075801L (no) 2005-04-12 2007-11-12 Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose

Country Status (11)

Country Link
US (1) US20080058299A1 (no)
EP (1) EP1868437A4 (no)
JP (1) JP2008538753A (no)
CN (1) CN101217874B (no)
AU (1) AU2006235453A1 (no)
BR (1) BRPI0609074A2 (no)
CA (1) CA2604400A1 (no)
EA (1) EA012246B1 (no)
IL (1) IL186369A0 (no)
NO (1) NO20075801L (no)
WO (1) WO2006110777A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US8883769B2 (en) * 2003-06-18 2014-11-11 White Mountain Pharma, Inc. Methods for the treatment of fibromyalgia and chronic fatigue syndrome
US20040259852A1 (en) * 2003-06-18 2004-12-23 White Hillary D. Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
TR201815853T4 (tr) 2005-10-12 2018-11-21 Besins Healthcare Sarl Hipogonadizmin tedavisinde kullanıma yönelik geliştirilmiş testosteron jeli.
US20090285893A1 (en) * 2008-05-19 2009-11-19 The Procter & Gamble Company Treatment of heart failure in women
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
CA2802799C (en) 2010-08-11 2015-03-03 University Of Kansas Delayed gelling agents
AU2011329782A1 (en) 2010-11-18 2013-06-20 White Mountain Pharma, Inc. Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
EP2833944A4 (en) 2012-04-06 2016-05-25 Antares Pharma Inc ADMINISTRATION OF TESTOSTERONE COMPOSITIONS BY NEEDLE-SUPPORTED NOZZLE INJECTION
CA3069079C (en) 2013-01-18 2022-04-19 Conocophillips Company Nanogels for delayed gelation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ES2423899T3 (es) * 2000-08-30 2013-09-25 Unimed Pharmaceuticals, Llc Método para aumentar las concentraciones de testosterona y esteroides relacionados en las mujeres
JP5039252B2 (ja) * 2000-08-31 2012-10-03 ユニメッド ファーマシューティカルズ，リミティド ライアビリティ カンパニー 性機能低下を治療するための医薬組成物及び方法

Also Published As

Publication number Publication date
EP1868437A1 (en) 2007-12-26
EA200702212A1 (ru) 2008-04-28
WO2006110777A1 (en) 2006-10-19
CN101217874B (zh) 2012-06-06
CA2604400A1 (en) 2006-10-19
BRPI0609074A2 (pt) 2010-02-17
AU2006235453A1 (en) 2006-10-19
CN101217874A (zh) 2008-07-09
EP1868437A4 (en) 2009-08-05
IL186369A0 (en) 2008-01-20
WO2006110777B1 (en) 2006-11-30
US20080058299A1 (en) 2008-03-06
JP2008538753A (ja) 2008-11-06
AU2006235453A2 (en) 2006-10-19
EA012246B1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
NO20075801L (no) Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose
CY1120904T1 (el) Βελτιωμενη γελη τεστοστερονης και μεθοδος χρησεως στην αγωγη του υπογοναδισμου
NO20045429L (no) Kombinasjon av organiske forbindelser
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20081042L (no) PPAR aktive forbindelser
WO2005053795A3 (en) Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
TW200602324A (en) Tetrahydro-indazole cannabinoid modulators cross reference to related applications
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
NO20055832L (no) Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
DE602004013971D1 (de) Marknagel zur Behandlung von proximalen Oberschenkelknochenbrüchen
NO20072461L (no) Fremstilling og anvendelse av bifenyl-4-yl-karbonylaminosyre derivater for behandling av fedme
ATE429645T1 (de) Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
WO2003101397A3 (en) Tetravalent dengue vaccines
WO2002043759A3 (en) Method and composition for modulating bone growth
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
NO20056161L (no) Formuleringer for behandling av artrittilstander
NO20072290L (no) Organiske forbindelser.
MXPA03006631A (es) Combinaciones de secuestrante(s) de los acidos biliares y de inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: UNIMED PHARMACEUTICALS, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: UNIMED PHARMACEUTICALS, LU

FC2A Withdrawal, rejection or dismissal of laid open patent application